Laetitia Dunogeant

Statistics

Publications

Citations

495

H-Index

Active since

2017

Affiliations

Hôpital Saint-Antoine(Current)

Bicêtre Hospital

Hôpital Cochin

Sorbonne Université

Assistance Publique – Hôpitaux de Paris

Laetitia Dunogeant is an author at Hôpital Saint-Antoine specializing in immune-mediated adverse events, immune-related adverse events, and rheumatology.

Publications per year

2017–2023

Publications

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

Rakiba Belkhir, S. Le Burel, Laetitia Dunogeant et al. · Annals of the Rheumatic Diseases · 2017 · 242 citations

Life Sciences, Immunology, Pharmacotherapy +17

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

S. Le Burel, Stéphane Champiat, Christine Mateus et al. · European Journal of Cancer · 2017 · 199 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

G. Martin de Frémont, N. Costedoat‐Chalumeau, Estibaliz Lazaro et al. · The Lancet Rheumatology · 2023 · 32 citations

Medicine, Gynecology, Obstetrics +12

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

Anne Murarasu, G. Guettrot-Imbert, Véronique Le Guern et al. · The Lancet Rheumatology · 2022 · 22 citations

Medicine, Maternal Health, Obstetrics +17

1–4 of 4